People
-
OBG subsidiary Noveayr Therapeutics has announced the appointments of former AstraZeneca VP, Respiratory, Simon Manners as CEO and former GSK Senior VP, Respiratory, Darrell Baker as Chairman. Noveayr is the parent company of Pharmaserve NW,… Read more . . .
-
Avalyn Pharma, which is developing its AP01 pirfenidone inhalation solution for the treatment of idiopathic pulmonary fibrosis (IPF), has named Lyn Baranowski as CEO, succeeding Bruce Montgomery. Baranowski was most recently Chief Operating Officer of… Read more . . .
-
Transpire Bio, which previously announced deals with Recipharm for development of four inhaled products, announced a new deal with INTO (Inhalation Together) for development of three additional inhaled products: TRB-5, TRB-6 and TRB-7. INTO is… Read more . . .
-
Transpire Bio, a start-up inhaled drug developer based in Florida, has announced the appointment of two more OINDP experts, naming William Schachtner as Chief Technical Operations Officer and Axel Perlwitz as Chief Regulatory Affairs Officer.… Read more . . .
-
Inhaled flecanide developer InCarda Therapeutics has named former Arena Pharmaceuticals executive Robert Lisicki as CEO, succeeding Grace Colón who the company says “intends to pursue other leadership opportunities within the life science space” but will continue… Read more . . .
-
Shortly after Savara announced the resignation of Badrul Chowdhury as its Chief Medical Officer, Philip Morris International (PMI) has announced the appointment of Chowdhury as PMI’s new Chief Life Sciences Officer, Smoke-Free Products, effective in… Read more . . .
-
Savara has announced the resignation of Badrul Chowdhury as Chief Medical Officer, effective September 9, 2022. Chowdhury, a former Director of the FDA’s Division of Pulmonary, Allergy, and Rheumatology Products, joined Savara as CMO in November… Read more . . .
-
Verona Pharma, which recently announced that a Phase 3 trial of its nebulized ensifentrine for the treatment of COPD met its primary endpoint, has announced the appointments of Matthew Casbon as VP of Sales, Marketing,… Read more . . .
-
Dry powder nebulizer developer Nob Hill Therapeutics announced the appointment of Noel Greenberger as its new CEO, replacing interim CEO Yun Li as of September 1, and said that it has received a Department of… Read more . . .
-
California-based nebulizer developer Respira Technologies has announced that Chief Operating Officer Brian Quigley will replace company founder Mario Danek as CEO, and Danek will take over the role of Chief Technology Officer. Quigley joined the… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden